Omnes Capital

Omnes Venture Capital provides financial assistance to startups in the ICT and life sciences sectors.

Business Model: B2B

Revenue: $40M

Employees: 51-200

Rankings

Detailed Omnes Capital Information

Geographic Data

Omnes Capital headquarters map

Address: 37 - 41 rue du Rocher

City: Paris

State: other

Zip: 75008

Country: FR

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$224M

Metrics

4,445,706Website Global Rank

2,200Website Monthly Traffic

Twitter Followers

Description

Omnes VC is the Venture Capital arm of Omnes Capital, a major player in private equity and infrastructure with €3.4 billion in assets under management and a 15 year + experience in: venture capital, buyout &a; growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fully independent. With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500 m in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Sigfox. Omnes VC is an early-investor in the french unicorn Blablacar.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
1/2019 Teach on Mars Venture Round 7.9M
1/2012 abakus solar Private Equity Round -
12/2018 Captain Tortue Funding Round -
9/2015 SeniorAdom Venture Round -
6/2009 Canevaflor Venture Round 1.7M
7/2007 VALOREM Venture Round 14.5M
1/2006 Viveo Group SAS Private Equity Round -
1/2007 TITANOBEL Venture Round -
4/2007 Sparus Software Series B 4.1M
7/2018 Marquetis Debt Financing -
1/2002 Nexeya Services Venture Round -
2/2009 Bizanga Series A 8M
2/2013 Exclusive Group Venture Round 67.2M
1/2002 Center Parcs Venture Round -
3/2013 Futuris SPA Venture Round 5.2M
11/2013 Pixium Vision Series A 20.3M
10/2022 Capsule Corp. Labs Seed Round 0
1/2013 Nomios Private Equity Round -
3/2006 SuperSonic Imagine Series A 11.9M
1/2000 Temis Venture Round -
5/2004 Pharma Omnium Series B 2.4M
10/2020 Biosyl Venture Round -
1/2006 Micromania Private Equity Round -
2/2012 eFrontech Private Equity Round -
11/2012 Adictiz Venture Round 2.5M
3/2013 EyeTechCare Series C 13M
11/2020 AlgoTherapeutix Series A 12M
1/2017 OCTIMET Oncology Series A 12M
9/2015 Bimedia Venture Round 10.2M
1/2000 Musiwave Venture Round -
9/2009 ESL - Turtle Entertainment Venture Round -
1/2000 Interactif Visuel Système Venture Round 1.5M
5/2012 Exosun Private Equity Round 15.5M
1/2003 COIFF&s;Idis Venture Round -
1/2006 Leyton France Private Equity Round -
12/2008 L4 Digital Private Equity Round -
9/2019 Newronika Series A 9.2M
1/2003 Meiosys Venture Round -
7/2013 Eratome group Private Equity Round 19.6M
1/2005 Eaux saint amand Venture Round -
1/2007 Aryes Private Equity Round -
8/2006 Augure Series C 5.8M
1/2000 Egencia Private Equity Round -
1/2007 Financiere Groupe Pommier Private Equity Round -
1/2016 MesDocteurs Seed Round 1.3M
9/2022 Ternoa Seed Round 7.3M
1/2004 Mutabilis Venture Round -
9/2013 ProDealCenter Venture Round 1.3M
1/2005 SGCC Venture Round -
3/2011 Ikaros Solar Private Equity Round -
8/2016 European Games Group Venture Round -
2/2017 Groupe Circet Venture Round -
6/2010 Scality Series A 0
1/2003 Traderforce Venture Round -
3/2019 Therapixel Series A 5.7M
1/2002 FAUCHON Paris Venture Round -
7/2008 H2i Technologies Venture Round 4M
3/2009 Keldelice Series A 1.9M
6/2021 Prima Vital Seed Round -
9/2005 Béryl Private Equity Round -
3/2009 FlexGen Private Equity Round -
5/2017 AB Tasty Series B 17M
12/2011 viavoo Series A 2M
1/2008 Grain D&s;Or Gel-Grain D&s;Or Frais Private Equity Round -
1/2010 Qualtera Private Equity Round -
7/2021 Coave Therapeutics Series B 0
10/2022 GOURMEY Series A 0
2/2015 Cogepart Venture Round 10.2M
1/2010 CircuLite Series C 32.5M
9/2011 Amakem Series A 25.2M
12/2022 Opensee Series A 11.7M
6/2010 Cytheris Series D 15M
4/2022 TagEnergy Venture Round 0
6/2012 Tennis Point Venture Round 6.2M
10/2008 SuperSonic Imagine Series B 25.7M
8/2012 Mister Bell Series A 3.5M
6/2012 Ividence Series B 4M
10/2019 Biosyl Venture Round -
1/2007 Verywear SAS Private Equity Round -
5/2011 Novate Medical Series B 12.4M
9/2009 Santen Pharmaceutical Post-IPO Equity 22M
12/2012 Poxel Series B 17.2M
9/2009 SpineGuard Series A 16.1M
10/2016 Oxatis Series D 0
1/2018 ENTEROME Debt Financing -
5/2014 ENTEROME Series B 15.3M
4/2016 ENTEROME Series C 16.4M
5/2017 Batiweb.com Venture Round -
3/2006 TRONICS GROUP Series D 0
5/2022 Domain Therapeutics Series A 0
1/2010 Oclio Venture Round -
6/2007 OCEAN SAS Private Equity Round -
6/2018 Nanomakers Venture Round 2M
9/2010 Neoen Private Equity Round 27.1M
2/2016 AB Tasty Series A 5.9M
12/2012 Greenbureau Seed Round 1.1M
5/2021 Ilmatar Venture Round 0
6/2011 Daltys Private Equity Round -
1/2009 ABC Distribution Private Equity Round -
4/2006 Santen Pharmaceutical Post-IPO Equity 31.5M
12/2009 Dealstreet Private Equity Round -
9/2015 TVSmiles Series B 5.6M
4/2012 Eptica Venture Round 9.1M
11/2009 Aquafadas Series A 1.8M
2/2010 arGEN-X Series A 4.5M
12/2018 ABMI Venture Round 12.4M
1/2009 Novaled Series C 0
9/2016 BIZAY / 360imprimir Series A 0
4/2013 SuperSonic Imagine Private Equity Round 0
6/2013 AT Internet Venture Round 8.3M
7/2016 Adents Series B 13.3M
11/2010 SuperSonic Imagine Series C 0
9/2011 TrustYou Series A 5M
4/2009 Scan &a; Target Series A 1.3M
9/2016 Bizay Series A 4.5M
1/2018 VSORA Series A 1.7M
1/2022 SeqOne Genomics Series A 0
10/2019 Solvionic Venture Round 4.4M
1/2000 Dynaction SA Venture Round -
6/2011 Aldebaran Robotics Series C 13M
6/2013 Complix Series B 15.6M
12/2015 Dispam Venture Round 12.7M
9/2019 Themis Bioscience Series D 44.1M
1/2006 DxO Labs Series A 12.8M
7/2018 GEEV Venture Round 3.5M
5/2019 SPHEREA Venture Round -
9/2011 SpineGuard Series B 5.4M
1/2002 Ortec Group Private Equity Round -
7/2007 DiBcom Series E 0
3/2017 MultiX Venture Round 0
1/2018 Pherecydes Pharma Series B 10.7M
12/2013 Cooltech Applications Venture Round 2.1M
2/2011 CellNovo Series B 48.3M
11/2022 Dust Mobile Series B 12.5M
4/2019 Bankin&s; Series B 22.6M
11/2003 Santen Pharmaceutical Post-IPO Equity 5.8M
12/2005 Novaled Series B 0
3/2014 Oxatis Series C 4.9M
12/2020 BIZAY / 360imprimir Series C 0
9/2022 WhiteLab Genomics Seed Round 10M
10/2006 Cytheris Series B 30.7M
12/2020 Bizay Series C 38.6M
5/2022 Therapixel Series B 0
2/2011 Complix Series A 2.8M
6/2008 Ariane Systems Venture Round 4.5M
9/2019 Wizaplace Venture Round 14.3M
3/2016 Intersec Series C 10M
1/2018 ForCity Series A 0
11/2019 TISSIUM Series B 43.2M
1/2017 Bankin&s; Series A 7.4M
7/2013 Scality Series C 0
11/2017 Coave Therapeutics Series B 22M
8/2015 Scality Series D 0
4/2008 Splendia Series B 4.8M
11/2018 Intersec Venture Round 9.1M
5/2022 Therapixel Series B 0
9/2009 ERA Biotech Series B 5.3M
5/2008 Miyowa Series B 0
7/2009 Stentys Series B 22.2M
10/2013 Opsona Series C 0
7/2012 Unafinance Private Equity Round -
10/2022 Qantev Series A 10M
3/2010 Electrostudio Energy Private Equity Round -
4/2021 Unseenlabs Series B 24.2M
4/2022 Skillup Venture Round 0
2/2023 The Exploration Company Series A 0
1/2023 VSORA Venture Round 0
1/2018 Themis Bioscience Series C 12M
12/2011 arGEN-X Series B 43.8M
4/2005 OpenTrust Series C 3.9M
7/2006 Exaprotect Series A 7.7M
4/2007 Idylis Series B 3.4M
6/2020 ENTEROME Series E 51.9M
10/2006 Ingenico Healthcare/e-ID Venture Round 8.3M
3/2009 BioVex Venture Round 40M
5/2023 DiogenX Series A 0
7/2020 AB Tasty Series C 0
2/2001 PayPal Series D 90M
11/2016 Themis Bioscience Series B 10.6M
8/2005 Eptica Series C 2M
4/2019 AgomAb Therapeutics Series A 23.6M
3/2021 AgomAb Therapeutics Series B 0
1/2002 Adenclassifieds Venture Round -
9/2008 Urbasolar Venture Round 5.8M
9/2008 Envivio Venture Round 0
12/2009 Envivio Debt 1M
3/2021 Elistair Series B 0
6/2015 Adents Series A 9.6M
11/2021 Quandela Series A 17M
11/2021 Quandela Venture Round 17M
1/2004 Clips Venture Round -
1/2008 Satys Venture Round -
2/2012 AEMI Group Venture Round 2M
1/2001 Si Automation Venture Round -
1/2004 Ideale Residence Mobile IRM Private Equity Round -
12/2021 Corteria Pharmaceuticals Seed Round 0
9/2010 ConfortVisuel Venture Round 2.6M
1/1999 Thalgo Venture Round -
5/2011 Trusted Shops Private Equity Round -
1/2004 HMY Group Private Equity Round -
1/2004 Maisons France Confort Venture Round -
6/2022 Qubit Pharmaceuticals Seed Round 16.9M
11/2008 Weole Energy Series A 2.6M
9/2011 usineadesign Series B 4M
1/2004 Salins Group Venture Round -
12/2019 Dust Mobile Series A 3.4M
12/2013 TISSIUM Series A 11M
1/2007 ECT Private Equity Round -
12/2018 Sentryo Series A 0
3/2016 TISSIUM Series A 25.5M
1/2006 Erenis S.A Venture Round -
6/2010 Oxatis Series B 4.9M
3/2010 Netzoptiker Venture Round 1.8M
3/2014 ACCO Semiconductor Series E 0
4/2013 European Games Group Venture Round -
4/2021 PeopleSpheres Venture Round 10.2M
1/2003 Terreal Venture Round -
4/2016 Babbler Series A 2.3M
7/2018 Antabio Series A 6.1M
3/2021 Artifakt Series A 4.4M
10/2020 SEKOIA Seed Round 0
1/2001 MGI Digital Technology Venture Round -
11/2010 plista Series A 3.5M
1/2002 3D Plus Venture Round -
1/2003 Denyall Venture Round -
4/2019 NH TherAguix Series A 14.6M
1/2008 LEXSI Private Equity Round -
1/2005 Tonnellerie Saury Private Equity Round -
1/2002 Media Sciences International Venture Round -
9/2017 Aero Negoce International Venture Round 13.9M
6/2018 Tiller Systems Series B 13.9M
1/2008 TIAMA inspection worldwide Private Equity Round -
9/2015 Capcom groupe Venture Round 10.7M
3/2012 ENTEROME Series A 0
1/2017 ENTEROME Series D 33.4M
4/2018 Tilkee Series A 4.3M
7/2010 Poxel Series A 21M
5/2006 NEMOPTIC Series D 0
3/2015 The Luneau Technology Group Private Equity Round -
8/2004 DIRICKX Group Private Equity Round -
6/2022 Qubit Pharmaceuticals Seed Round 0
5/2022 Therapixel Series B 0
5/2022 Domain Therapeutics Series A 0
4/2022 Skillup Venture Round 0
1/2022 SeqOne Genomics Series A 0
12/2021 Corteria Pharmaceuticals Seed Round 0
11/2021 Quandela Venture Round 0
7/2021 Coave Therapeutics Series B 0
6/2021 Prima Vital Seed Round -
5/2021 Ilmatar Venture Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.